Provided by Tiger Fintech (Singapore) Pte. Ltd.

X4 Pharmaceuticals Inc

0.2946
-0.0191-6.09%
Post-market: 0.2919-0.0027-0.92%19:52 EDT
Volume:2.69M
Turnover:815.26K
Market Cap:50.24M
PE:-3.43
High:0.3233
Open:0.3203
Low:0.2900
Close:0.3137
Loading ...

January 2025's Top US Penny Stocks To Consider

Simply Wall St.
·
22 Jan

Cantor Fitzgerald Sticks to Its Buy Rating for X4 Pharmaceuticals (XFOR)

TIPRANKS
·
16 Jan

XFOR: Receives €28.5 Upfront for Licensing Agreement with Norgine…

Zacks Small Cap Research
·
15 Jan

X4 Pharmaceuticals Price Target Maintained With a $1.50/Share by HC Wainwright & Co.

Dow Jones
·
14 Jan

Analysts Have Conflicting Sentiments on These Healthcare Companies: Travere Therapeutics (TVTX), Treace Medical Concepts (TMCI) and X4 Pharmaceuticals (XFOR)

TIPRANKS
·
14 Jan

Stifel Nicolaus Remains a Buy on X4 Pharmaceuticals (XFOR)

TIPRANKS
·
14 Jan

X4 Pharmaceuticals Partners With Norgine to Commercialize Immunotherapy in Europe, Other Regions

MT Newswires Live
·
13 Jan

BRIEF-X4 Pharmaceuticals And Norgine Enter Into Exclusive Licensing Agreement To Commercialize Mavorixafor In Europe, Australia, And New Zealand

Reuters
·
13 Jan

X4 Pharmaceuticals and Norgine Enter Into Exclusive Licensing Agreement to Commercialize Mavorixafor in Europe, Australia, and New Zealand

THOMSON REUTERS
·
13 Jan

X4 Pharmaceuticals Inc - to Submit Maa to Ema for Mavorixafor in Whim Syndrome

THOMSON REUTERS
·
13 Jan

X4 Pharmaceuticals Inc - to Receive €28.5 Mln Upfront, up to €226 Mln in Milestones

THOMSON REUTERS
·
13 Jan

Grace Therapeutics And 2 Other US Penny Stocks Worth Watching

Simply Wall St.
·
21 Dec 2024

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
04 Dec 2024

Spotlight On 3 US Penny Stocks With At Least $60M Market Cap

Simply Wall St.
·
21 Nov 2024

B. Riley Adjusts X4 Pharmaceuticals Price Target to $0.50 From $1, Maintains Neutral Rating

MT Newswires Live
·
18 Nov 2024

X4 Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
15 Nov 2024